The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Thermo Fisher Scientific has agreed to acquire the advanced bioprocessing business of Becton, Dickinson and Company (BD), a Franklin Lakes, New Jersey-based medical technology company.
The bioprocessing business combines a technical services...
Ajinomoto Althea, a San Diego, California-headquartered contract development and manufacturing organization, has opened a new antibody drug conjugate and highly potent fill/finish facility near its existing campus in San Diego.
The...
Olon S.p.A., an Italy-headquartered contract development and manufacturing organization of active pharmaceutical ingredients (APIs) and a generics supplier, has acquired a local generics chemical operations API manufacturing facility in Mahad,...
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, is increasing manufacturing capacity at its Copenhagen, Denmark facility.
The Copenhagen facility will add a single-use bioreactor...
Kaneka Corporation, a Tokyo-headquartered chemical manufacturing company, has installed continuous manufacturing equipment for small-molecule pharmaceutical products at Kaneka’s Singapore facility. Kaneka announced the installment in July 2018 and...
Gerresheimer, a manufacturer of special glass and plastic products to the pharmaceutical industry, has agreed to acquire Sensile Medical AG, an Olten, Switzerland-based medical technology company, in a deal worth up to EUR 350 million ($409...
Sterigenics, a provider of contract sterilization, gamma technologies and medical isotopes, is building a new facility in Markham Vale North in Chesterfield/Derbyshire, UK.
The new 60,000-square-foot facility will include the installation of a...
West Pharmaceutical Services, a manufacturer of packaging and delivery systems for injectable drugs and healthcare products, has opened a new facility in Waterford, Ireland, a global center of excellence for West's manufacturing network, and has...
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), has agreed to acquire Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing...
PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, has appointed Salim Haffar, as Chief Executive Officer to take effect later in 2018. Haffar is currently President of Aptar Pharma, a manufacturer of...
AGC, a Tokyo-headquartered manufacturer of glass and chemicals, is planning an expansion of its facilities in Chiba, Japan to increase the company’s manufacturing capacity for pharmaceutical intermediates and active pharmaceutical ingredients...
SK Holdings, a Seoul, South Korea-based holding company of SK Group, has agreed to acquire Ampac Fine Chemicals (AFC), a Rancho Cordova, California-headquartered contract manufacturer of active pharmaceutical ingredients (APIs) and intermediates....
Catalent Pharma Solutions has appointed Marlene Leuenberger as General Manager of the company’s Drug Development Center of Excellence in Somerset, New Jersey.
Leuenberger has over 25 years’ management experience in engineering, quality operations,...
Almac Group, a Craigavon, UK-based contract development and manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs) and drug products, plans to invest £375,000 ($496,000) in additional nuclear magnetic resonance (NMR)...
Catalent Pharma Solutions plans to adopt an optofluidic platform for cell-line development provided by Berkeley Lights (BLI), an Emeryville, California-headquartered company developing platforms for biopharmaceutical processes.
BLI’s Beacon...
